{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ANR.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANR.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANR.AU\",,,,,undefined,":{"symbol":"ANR.AU","market":"AU","secType":"STK","nameCN":"ANATARA LIFESCIENCES LTD","latestPrice":0.045,"timestamp":1741065120000,"preClose":0.042,"halted":0,"volume":19197,"delay":0,"changeRate":0.071429,"change":0.003,"floatShares":125359802,"shares":213383727,"eps":-0.01044,"lyrEps":-0.009673,"pbRate":7.08,"amount":894,"amplitude":0.071429,"volumeRatio":0.2126389293841049,"dividePrice":0,"prevYearClose":0.047,"fiveDayClose":0.055,"twentyDayClose":0.057},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANR.AU\",,,,,undefined,":{"symbol":"ANR.AU","floatShares":125359802,"roa":"-76.07%","roe":"-147.32%","lyrEps":-0.009673,"volumeRatio":0.2126389293841049,"shares":213383727,"dividePrice":0,"high":0.048,"amplitude":0.071429,"preClose":0.042,"low":0.045,"week52Low":0.029,"pbRate":"7.08","psRate":"38.33","week52High":0.073,"institutionHeld":0,"latestPrice":0.045,"eps":-0.01044,"divideRate":0,"volume":19197,"delay":0,"ttmEps":-0.01044,"open":0.048,"prevYearClose":0.047,"prevWeekClose":0.042,"prevMonthClose":0.042,"prevQuarterClose":0.047,"fiveDayClose":0.055,"twentyDayClose":0.057,"sixtyDayClose":0.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANR.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANR.AU\",market:\"AU\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ANR.AU\",params:#limit:6,delay:false,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.005629}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANR.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507574784","title":"Anatara Lifesciences Receives Australian Patent for Gastrointestinal Product; Shares Fall 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507574784","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507574784?lang=en_us&edition=fundamental","pubTime":"2025-01-29 10:43","pubTimestamp":1738118581,"startTime":"0","endTime":"0","summary":"Anatara Lifesciences  received a patent for its Gastrointestinal ReProgramming   product, under the invention title \"Gastrointestinal Health Composition,\" according to a Tuesday filing with the Australian bourse.The intellectual property protection, granted by the Australian Patent Office, has a 20-year term from Oct. 9, 2020, to Oct. 9, 2040, the filing said.The GaRP product is a complementary medicine designed to tackle the root causes of chronic gastrointestinal conditions like irritable bowel syndrome and inflammatory bowel disease, per the filing.Its shares fell 8% in afternoon trade Wednesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7067","XAO.AU","XKO.AU","ANR.AU","XJO.AU"],"gpt_icon":0},{"id":"2506530875","title":"BRIEF-Anatara Lifesciences Says Australian Patent Granted For GARP Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2506530875","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506530875?lang=en_us&edition=fundamental","pubTime":"2025-01-28 09:03","pubTimestamp":1738026192,"startTime":"0","endTime":"0","summary":"BRIEF-Anatara Lifesciences Says Australian Patent Granted For GARP ProductJan 28 (Reuters) - Anatara Lifesciences Ltd ANR.AX:AUSTRALIAN PATENT GRANTED FOR GARP PRODUCTFurther company coverage: ANR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nFWN3ON170:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","ANR.AU","BK7067"],"gpt_icon":0},{"id":"2506531430","title":"Anatara Lifesciences Ltd - Australian Patent Granted for Garp Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2506531430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506531430?lang=en_us&edition=fundamental","pubTime":"2025-01-28 07:45","pubTimestamp":1738021548,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3ON170:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","ANR.AU"],"gpt_icon":0},{"id":"2492374474","title":"Anatara Lifesciences Ltd-Share Purchase Plan Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2492374474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492374474?lang=en_us&edition=fundamental","pubTime":"2024-12-20 09:23","pubTimestamp":1734657801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUE5M0LKF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","ANR.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16}]}}